Lacosamide
NDC 72205-220, Lacosamide, injection, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-220
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215979
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/72205-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LACOSAMIDE10 mg/mL
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-220-07 | 72205022007 | 10 VIAL in 1 CARTON (72205-220-07) / 20 mL in 1 VIAL (72205-220-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/a024081a-e131-4e88-967d-40155651a945
Use it
Look up 72205-220 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-220 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-220. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.